您的位置: 首页 > 农业专利 > 详情页

Tuberculosis vaccines comprising antigens expressed during the latent infection phase
专利权人:
Statens Serum Institut
发明人:
AAGAARD, Claus,VINGSBO-LUNDBERG, Carina,ANDERSEN, Peter
申请号:
AU2013206297
公开号:
AU2013206297A1
申请日:
2013.06.13
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
#$%^&*AU2013206297A120130704.pdf#####ABSTRACT The invention is related to an immunogenic composition, vaccine or pharmaceutical 5 composition for preventing, boosting or treating infection caused by a species of the tuberculosis complex (M. tuberculosis, M. bovis, M. africanum, M. microti). The immunogenic composition, vaccine or pharmaceutical composition comprise a fusion polypeptide, which comprises one or more starvation antigens from M.tuberculosis, the units of the fusion polypeptide being M. tuberculosis antigens. Further, the invention is related to 10 the use of a vaccine comprising a fusion polypeptide sequence or nucleic acid sequence of the invention given at the same time as BCG, either mixed with BCG or administered separately at different sites or routes for preparing said immunogenic composition, vaccine, or pharmaceutical composition.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充